mycophenolic acid tablet (enteric-coated)
jamp pharma corporation - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 360mg - mycophenolic acid (mycophenolate sodium) 360mg - immunosuppressive agents
mycophenolic acid tablet (enteric-coated)
jamp pharma corporation - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 180mg - mycophenolic acid (mycophenolate sodium) 180mg - immunosuppressive agents
myfortic- mycophenolic acid tablet, delayed release
novartis pharmaceuticals corporation - mycophenolate sodium (unii: wx877sqi1g) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolic acid 360 mg - myfortic® (mycophenolic acid) is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant. myfortic is indicated for the prophylaxis of organ rejection in pediatric patients 5 years of age and older who are at least 6 months post kidney transplant. myfortic is to be used in combination with cyclosporine and corticosteroids. myfortic delayed-release tablets and mycophenolate mofetil (mmf) tablets and capsules should not be used interchangeably without physician supervision because the rate of absorption following the administration of these two products is not equivalent. myfortic is contraindicated in patients with a hypersensitivity to mycophenolate sodium, mycophenolic acid (mpa), mycophenolate mofetil, or to any of its excipients. reactions like rash, pruritus, hypotension, and chest pain have been observed in clinical trials and post marketing reports [see adverse reactions (6)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors preg
myfortic gastro-resistant tablet 180 mg
novartis (singapore) pte ltd - mycophenolate sodium 192.4mg eqv mycophenolic acid - enteric coated tablet - 192.4mg - mycophenolate sodium 192.4mg eqv mycophenolic acid 180mg
myfortic gastro-resistant tablet 360 mg
novartis (singapore) pte ltd - mycophenolate sodium 384.8mg eqv mycophenolic acid - tablet, film coated - 384.8 mg - mycophenolate sodium 384.8mg eqv mycophenolic acid 360 mg
co mycophenolate comprimé
cobalt pharmaceuticals company - mofétilmycophénolate - comprimé - 500mg - mofétilmycophénolate 500mg - immunosuppressive agents
sandoz mycophenolic acid tablet (enteric-coated)
sandoz canada incorporated - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 180mg - mycophenolic acid (mycophenolate sodium) 180mg - immunosuppressive agents
sandoz mycophenolic acid tablet (enteric-coated)
sandoz canada incorporated - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 360mg - mycophenolic acid (mycophenolate sodium) 360mg - immunosuppressive agents
mar-mycophenolic acid tablet (enteric-coated)
marcan pharmaceuticals inc - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 180mg - mycophenolic acid (mycophenolate sodium) 180mg - immunosuppressive agents
mar-mycophenolic acid tablet (enteric-coated)
marcan pharmaceuticals inc - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 360mg - mycophenolic acid (mycophenolate sodium) 360mg - immunosuppressive agents